iSERA Lifesciences Limited (BOM:534920)

iSERA Lifesciences Revenue

In the fiscal year ending March 31, 2026, iSERA Lifesciences had annual revenue of 13.69M INR with 416.03% growth. iSERA Lifesciences had revenue of 11.63M in the quarter ending March 31, 2026, with 338.46% growth.

• Revenue: 13.69M
• Revenue Growth: +416.03%
• P/S Ratio: 70.50
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 964.76M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	13.69M	11.03M	416.03%
Mar 31, 2025	2.65M	-	-
Mar 31, 2024	-	-	-
Mar 31, 2023	-	-	-
Mar 31, 2022	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 17, 2026

Data Sources Report a data error